Health and Fitness

Reliv Says The Battle Against Heart Disease Can Be Won

This February, in honor of American Heart Month, Reliv International, a nutrition and direct selling company, is encouraging local residents to be proactive about their heart health. The proper approach, Reliv says, should include more than just avoiding certain activities and foods. "When it comes to heart health, many experts tend to focus on the 'don'ts' - don't eat red meat, don't smoke, etc., " said Dr. Carl Hastings, chief scientific officer of Reliv International. "And while there's no doubt that those steps are significant, of equal importance are the 'dos' or the positive actions that can actually prevent the onset of heart disease." Hastings says that by following the action steps below, people can gradually change their behavior and develop heart-friendly habits: - Get a physical: Although you may be feeling fine, you still may have high blood pressure or cholesterol levels that are out of whack. Therefore, one of the most important things you can do to improve your heart health is get a physical.

Corventis Announces FDA Clearance And US Launch Of The NUVANT trade; Mobile Cardiac Telemetry System

Corventis, Inc., a developer of wireless cardiovascular solutions, announced today that it has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its NUVANT™ Mobile Cardiac Telemetry (MCT) System for the detection of non-lethal arrhythmias. In addition, the company announced that its Monitoring Center has been approved by the Center for Medicare & Medicaid Services (CMS) as an Independent Diagnostic Testing Facility (IDTF). Corventis has also received approval to bill for services provided to patients with Medicare and several commercial insurers, paving the way for the NUVANT MCT System to be available across the United States. "The NUVANT MCT System represents the next generation of noninvasive, ambulatory arrhythmia monitoring, " said Leslie Saxon, M.D., chief, division of cardiology, Keck School of Medicine at the University of Southern California, Los Angeles, who is the founder of the annual Body Computing Conference and a pioneer in the field of networked medical devices.

NERI Research Findings Show That Erectile Dysfunction May Be Early Warning Of Future Cardiovascular Disease

In the first study of its kind, New England Research Institutes, Inc. (NERI) in collaboration with the Division of Cardiology, San Francisco General Hospital and the University of California, San Francisco tested whether erectile dysfunction (ED) can be used to reclassify patients according to their future risk of developing cardiovascular disease (CVD) beyond traditional risk factors (such as smoking, high blood pressure, high cholesterol, etc). Results of the 12-year research study are published in the January 26, 2010 issue of the Journal of the American College of Cardiology and show that ED may be a warning sign of a future cardiovascular event like heart attack, stroke, atherosclerosis, coronary artery bypass graft surgery, and congestive heart failure. However, while ED is significantly related to CVD independent of traditional risk factors, it does not improve the prediction of who will and will not develop CVD beyond these risk factors. "This is an important study because it is the first to explicitly test whether ED can predict the future development of CVD beyond a predictive tool called the Framingham risk score, " said Andre Araujo, PhD, Director of Epidemiology at NERI and lead researcher of the study.

FDA Approves For Permanent Treatment Of Advanced Heart Failure Assist Device Pioneered By Texas Heart Institute At St. Luke's Episcopal Hospital

The federal Food and Drug Administration today approved a continuous-flow heart-assist device pioneered at the Texas Heart Institute (THI) at St. Luke's Episcopal Hospital (SLEH) for use as a permanent treatment for advanced heart failure. The approval of the pump device, the HeartMate II, follows several years of clinical trials and is seen as a major milestone for patients in the United States. In any given year there are some 250, 000 people who suffer from advanced heart failure, while only about 2, 000 heart transplants are performed annually in the U.S. In addition to the need far outpacing the supply of donor hearts, many patients, due to a variety of circumstances such as age and medical complications, are simply not candidates for heart transplants. The device was previously approved as a way to "bridge" patients until a donor heart could be found. Today's approval of the device as a destination (meaning permanent) therapy means those patients awaiting transplants, or those ineligible for transplants, have a badly needed new treatment option.

Post-Katrina Stress, Heart Problems Linked

Chronic stress following Hurricane Katrina contributed to a three-fold increase in heart attacks in New Orleans more than two years after levee breaches flooded most of the city, according to researchers at Tulane University School of Medicine. Those suffering heart attacks post-Katrina also were significantly more likely to receive coronary interventions, particularly angioplasty to reopen clogged coronary arteries, which suggests these patients may have more severe disease, according to new data presented on Sunday (March 29, 2009) at the American College of Cardiology's 58th Annual Scientific Session in Orlando, Fla. The analysis is one of the first to look at the long-term impact on public health resulting from major disasters such as Hurricane Katrina. Previous studies have found short-term increases in heart attacks and other cardiac events occurring in the immediate hours to weeks after major disasters such as earthquakes or volcano eruptions. "Our data show that the effects of an acute major disaster are not limited to its immediate aftermath, but can linger on for a prolonged duration, " said lead researcher Dr.

What Do Sleep, Diabetes And Red Have In Common With Heart Disease?

OSA: The Sleep Disorder that's Deadly for Your Heart If you're a loud snorer who doesn't feel rested enough during the day, you may be unwittingly putting your heart at risk. That's because you could have untreated Obstructive Sleep Apnea (OSA), a disorder directly linked to several cardiovascular syndromes that cause premature death. OSA, in which the upper airway becomes blocked repeatedly during sleep, is a condition that affects 24% of men and 8% of women. Over the past 10 years, several studies have linked OSA to high blood pressure. Patients who require three or more medications to control hypertension have an 80% chance of having OSA. Also, compared to the general population the prevalence of OSA is significantly higher among patients with chronic heart failure (50% higher), a trial fibrillation (50% higher) and coronary artery disease (40% higher). For patients with these heart conditions, a sleep study is crucial; if their OSA goes undiagnosed and untreated, they will have a doubled risk for death during the next 5 years.

Heart Murmurs In Children: Not Always A Serious Problem

Your 3-year-old's doctor discovers a heart murmur during a visit for a mild cold with fever and recommends referral to a pediatric cardiologist. You worry and wonder how your healthy, active child could possibly have a heart problem. "Finding out that your child has a heart murmur causes a great deal of anxiety, " said Dr. Louis Bezold, associate professor of pediatrics and chief of the division of pediatric cardiology, University of Kentucky College of Medicine, and co-director of the Kentucky Children's Heart Center. "It is a common misconception that all murmurs are serious, but this is not the case. Murmurs are actually extremely common findings in infants and children. In fact, most children will have a murmur at some point during childhood. According to Bezold, a murmur is simply an extra noise in addition to the normal heart sounds (so-called "lub-dub") heard using a stethoscope. When your doctor listens to your child's heart they will note the location, intensity and other characteristics of the extra sound.

ARCA Announces Publication Of Bucindolol Data In Circulation: Heart Failure

ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically targeted therapies for heart failure and other cardiovascular disease, today announced that the paper "An alpha-2C-Adrenergic Receptor Polymorphism Alters the Norepinephrine Lowering Effects and Therapeutic Response of the Beta Blocker Bucindolol in Chronic Heart Failure" was published in the January 2010 edition of the peer-reviewed journal Circulation: Heart Failure ( http://circheartfailure.ahajournals.org ). The paper concludes that in the Beta-Blocker Evaluation of Survival Trial (BEST) adrenergic polymorphism substudy, the norepinephrine lowering and clinical therapeutic responses to bucindolol were strongly influenced by the alpha-2C adrenergic receptor genotype. "These data indicate that in heart failure patients in the study, the norepinephrine lowering effects of bucindolol are under genetic control, and that the degree of lowering may be kept in a therapeutic range by baseline screening using alpha-2C-adrenergic receptor genetic biomarkers, " said Michael R.

Positron Sells Attrius trade; PET Scanner

Positron Corporation (OTCBB:POSC) a molecular imaging solutions company focused on Nuclear Cardiology, announced today the sale of its AttriusTM PET scanner to Manhattan based, Gramercy Cardiac Diagnostic Services, owned by prominent New York City cardiologist, Dr. Peter Rentrop. The Attrius™ is the only PET scanner on the market optimized for myocardial perfusion imaging. The Attrius™ has several specialized features making it the scanner of choice for nuclear cardiologist's who value high quality PET imagery and cardiovascular specific interpretation tools, assisting in accurately assessing the patient's condition. Joseph Oliverio, Chief Technology Officer of Positron states, "We are proud to sell Positron's newly released AttriusTM PET scanner to Dr. Rentrop. We appreciate his confidence in Positron Corporation in purchasing multiple systems to date." Oliverio further stated, "Positron has the ideal solution for thousands of cardiology groups looking to improve their diagnostic accuracy at an affordable price.

Study Shows Link Between Lung Disease Heart Function

A new study from Columbia University Medical Center researchers, has found that the heart's ability to pump effectively is diminished among people with a common lung disease, even in people with no or mild symptoms. Published in the Jan. 21, 2010 issue of the New England Journal of Medicine, the research is the first to show a strong link between heart function and mild COPD (chronic obstructive pulmonary disease). COPD is the fourth leading cause of death in the United States, and it is strongly associated with smoking. COPD often involves loss of lung tissue, called emphysema, as well as narrowed airways, persistent cough, and mucus production, known as chronic obstructive bronchitis. Both of these abnormalities impair the flow of air in the lungs and make breathing more difficult over time. "Heart failure caused by lung disease is well documented in patients with severe COPD, but was not thought to occur in patients with mild COPD, " said Graham Barr, M.D., Dr. PH., assistant professor of medicine and epidemiology at Columbia University Medical Center, an internist at NewYork-Presbyterian Hospital/Columbia, principal investigator of the MESA Lung Study, and lead author of the paper.

Fast: [10] [20] [30] [40]
Health and Fitness © Padayatra Dmytriy
Designer Padayatra Dmytriy